Kidney
Newsletter
Keeping you up to date with the latest exciting advances and discussions in nephrology
Meet the editors
To contact a Vifor medical representative please email medinfo@viforpharma.com
SHPT

Global Medical Lead
Hyperphosphataemia

Global Medical Affairs Director

Senior Global Medical
Affairs Director

Global Medical Lead

Senior Medical Liaison
Netherlands
FOOTNOTES
AAV, anti-neutrophil cytoplasmic auto-antibody-associated vasculitis; CKD-aP, chronic kidney disease-associated pruritus; CKD-MBD, chronic kidney disease-mineral bone disorder; HK, hyperkalaemia.